Yoshitaka Saito

Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications

Pharmaceutical Verification of Chemotherapy-induced Adverse Events

Pharmaceutical Verification of Chemotherapy-induced Adverse Events

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: August 03, 2026

Factors Associated With Rash in Elderly Patients Receiving Carboplatin Plus Pemetrexed With Dexamethasone Prophylaxis.

Factors Associated With Rash in Elderly Patients Receiving Carboplatin Plus Pemetrexed With Dexamethasone Prophylaxis.

Journal: Anticancer research
Published: June 08, 2026

Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis.

Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis.

Journal: In vivo (Athens, Greece)
Published: May 12, 2026

Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.

Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.

Journal: Anticancer research
Published: March 13, 2026

Prediction of chemotherapy-induced nausea during irinotecan-based treatment based on prior oxaliplatin-induced symptoms in colorectal cancer.

Prediction of chemotherapy-induced nausea during irinotecan-based treatment based on prior oxaliplatin-induced symptoms in colorectal cancer.

Journal: International journal of clinical oncology
Published: February 26, 2026

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Journal: Japanese journal of clinical oncology
Published: February 16, 2026

Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer.

Identification of factors associated with rash during gemcitabine plus nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 09, 2026

Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.

Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.

Journal: International journal of clinical oncology
Published: January 09, 2026

Effect of polymerase chain reaction-based antifungal stewardship on candidemia management in small- and medium-sized hospitals.

Effect of polymerase chain reaction-based antifungal stewardship on candidemia management in small- and medium-sized hospitals.

Journal: Journal of pharmaceutical health care and sciences
Published: December 12, 2025

Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment.

Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment.

Journal: Anticancer research
Published: September 23, 2025

Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment.

Risk Factor Analysis for Bevacizumab-induced Severe Hypertension in Advanced Breast Cancer Treatment.

Journal: Anticancer research
Published: September 22, 2025

Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report.

Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report.

Journal: Journal of pharmaceutical health care and sciences
Published: September 04, 2025
Showing 1-12 of 131

Last Updated: 09/26/2026